Trading volume is going to be thin today, due to the holiday, so I wanted to take this chance to say that I I am thankful for the support of my team and more importantly you the reader. I hope you all had a happy Thanksgiving.
It says to stay away from investing in Chinese stocks during our trade battles with that nation.
It’s a good thing that someone forgot to give Daniel Zhang a copy.
Here’s the thing. While tariffs the U.S. imposed on some Chinese goods have slowed factory output over there, that has hardly filtered down to the nation’s thriving Web sector.
And that’s where Zhang is really shining right now. He’s the CEO of Internet giant Alibaba Group Holding Ltd. (BABA) and just pulled off a remarkable coup.
In the first hour of the firm’s recent Single’s Day shopping bonanza Nov. 11, it brought in $13 billion. No, that’s not a misprint. Alibaba sold more goods in 60 minutes than hundreds of U.S. firms do in a year.
By contrast, that’s roughly 80% of what Amazon.com Inc. (AMZN) pulled in last quarter.
Imagine if all it took to treat a case of cancer was taking out the trash.
Now I want you to imagine that your body could do it all for you.
Hold that thought. Because a tech platform with that very task in mind is set to hit the market sooner than you think and will target a field set to be worth more than $160 billion.
Here’s the thing. Several life sciences firms are hard at work perfecting a new class of drugs known as “degraders.”
Let me explain. The root of many diseases lies in misguided proteins that bind together. So, the idea here is to come up with a new class of drugs that activate the body’s own molecular trash disposal systems.
This is one of the most exciting breakthroughs I’ve come across in many years. I believe it puts us close to the day when one pill can cure dozens, if not all, diseases.
By now, I think it’s safe to say that Jim Cramer was dead wrong.
And I was right on the money.
Here’s the thing. I remember very clearly the day that Amazon.com Inc. (AMZN) crossed the $1,000 mark on May 31, 2017.
Cramer, the host of CNBC’s Mad Money looked at the price and slammed it. He said that “psychologically” $1,000 is a lot to pay for a stock he felt was getting ahead of itself.
As the saying goes, that was then and this is now.
No doubt, the tech leader hit a rough patch late last year with the rest of the market. And it has come under fire recently as part of the Big Tech backlash.
Yet, below-expected earnings reports for Q2 and Q3 of this year could only pull Amazon down into the $1,700 range, still far above what Cramer was worrying about.
Not only that, but the “King of E-commerce” is well positioned for another historic moment. It’s roughly 15% away from having a $1 trillion market cap, and most of that would just be regaining lost ground
And today, you’ll see why I still firmly believe the stock will hit at least $3,000 a share – and likely much, much more than that…
Roku Inc. (ROKU) has been having some good days in early November, and it’s perfectly positioned to capitalize on the rise of streaming; but its future is not necessarily certain. The streaming platform has had to deal with some price instability after its quick rise, and now the question of whether its freemium pricing model can meet consumer demand is surfacing. Meanwhile, the digital streaming market is full of tough competitors – and there are two more prominent than ever, ready to hash it out. This is one battle you need to watch closely, as the winner could spell out huge profits for whomever latches on now. Click here to watch.